JP Morgan Chase’s Safeguard Scientifics, Inc. SFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-21
| Closed | -$16 | – | 8096 |
|
|
2023
Q4 | $16 | Buy |
21
+5
| +31% | +$5 | ﹤0.01% | 7387 |
|
|
2023
Q3 | $16 | Buy |
+16
| New | +$21 | ﹤0.01% | 7224 |
|
|
2021
Q4 | – | Sell |
-187
| Closed | -$1K | – | 7070 |
|
|
2021
Q3 | $1K | Sell |
187
-21,856
| -99% | -$175K | ﹤0.01% | 6420 |
|
|
2021
Q2 | $170K | Sell |
22,043
-59,238
| -73% | -$404K | ﹤0.01% | 5316 |
|
|
2021
Q1 | $554K | Sell |
81,281
-1,349
| -2% | -$9.79K | ﹤0.01% | 4615 |
|
|
2020
Q4 | $527K | Buy |
82,630
+46,015
| +126% | +$287K | ﹤0.01% | 4336 |
|
|
2020
Q3 | $193K | Sell |
36,615
-2,501
| -6% | -$14.9K | ﹤0.01% | 4379 |
|
|
2020
Q2 | $273K | Sell |
39,116
-21,863
| -36% | -$138K | ﹤0.01% | 4123 |
|
|
2020
Q1 | $339K | Buy |
60,979
+4,019
| +7% | +$35.9K | ﹤0.01% | 4031 |
|
|
2019
Q4 | $625K | Buy |
56,960
+19,880
| +54% | +$227K | ﹤0.01% | 4123 |
|
|
2019
Q3 | $420K | Buy |
37,080
+31,726
| +593% | +$378K | ﹤0.01% | 4248 |
|
|
2019
Q2 | $65K | Sell |
5,354
-6,698
| -56% | -$78.4K | ﹤0.01% | 5081 |
|
|
2019
Q1 | $131K | Buy |
12,052
+6,525
| +118% | +$66.2K | ﹤0.01% | 4801 |
|
|
2018
Q4 | $47K | Sell |
5,527
-111,244
| -95% | -$970K | ﹤0.01% | 5108 |
|
|
2018
Q3 | $1.09M | Buy |
116,771
+62,998
| +117% | +$684K | ﹤0.01% | 3858 |
|
|
2018
Q2 | $688K | Buy |
53,773
+48,720
| +964% | +$629K | ﹤0.01% | 4015 |
|
|
2018
Q1 | $62K | Sell |
5,053
-292
| -5% | -$3.55K | ﹤0.01% | 4746 |
|
|
2017
Q4 | $60K | Buy |
5,345
+4,371
| +449% | +$56K | ﹤0.01% | 4837 |
|
|
2017
Q3 | $13K | Sell |
974
-1,933
| -66% | -$23.8K | ﹤0.01% | 4686 |
|
|
2017
Q2 | $35K | Sell |
2,907
-14,316
| -83% | -$169K | ﹤0.01% | 4421 |
|
|
2017
Q1 | $219K | Sell |
17,223
-17,933
| -51% | -$226K | ﹤0.01% | 4037 |
|
|
2016
Q4 | $472K | Sell |
35,156
-51,732
| -60% | -$638K | ﹤0.01% | 3802 |
|
|
2016
Q3 | $1.13M | Sell |
86,888
-664
| -0.8% | -$8.8K | ﹤0.01% | 3077 |
|
|
2016
Q2 | $1.09M | Buy |
87,552
+664
| +0.8% | +$8.91K | ﹤0.01% | 3131 |
|
|
2016
Q1 | $1.15M | Buy |
86,888
+10,000
| +13% | +$126K | ﹤0.01% | 3006 |
|
|
2015
Q4 | $1.11M | Sell |
76,888
-62
| -0.1% | -$1K | ﹤0.01% | 3073 |
|
|
2015
Q3 | $1.2M | Sell |
76,950
-885
| -1% | -$15.9K | ﹤0.01% | 3019 |
|
|
2015
Q2 | $1.51M | Buy |
77,835
+2,764
| +4% | +$50.7K | ﹤0.01% | 3068 |
|
|
2015
Q1 | $1.36M | Hold |
75,071
| – | – | ﹤0.01% | 3060 |
|
|
2014
Q4 | $1.49M | Sell |
75,071
-176
| -0.2% | -$3.39K | ﹤0.01% | 3133 |
|
|
2014
Q3 | $1.38M | Hold |
75,247
| – | – | ﹤0.01% | 3151 |
|
|
2014
Q2 | $1.56M | Hold |
75,247
| – | – | ﹤0.01% | 2662 |
|
|
2014
Q1 | $1.67M | Sell |
75,247
-2,540
| -3% | -$50.5K | ﹤0.01% | 2630 |
|
|
2013
Q4 | $1.56M | Sell |
77,787
-15,102
| -16% | -$267K | ﹤0.01% | 2908 |
|
|
2013
Q3 | $1.46M | Buy |
92,889
+9,032
| +11% | +$139K | ﹤0.01% | 3014 |
|
|
2013
Q2 | $1.35M | Buy |
+83,857
| New | +$1.33M | ﹤0.01% | 3074 |
|
Other funds holding SFE
CP
RA
FWM
HNB
JP Morgan Chase's SFE Position: Q1 2024 in Review
JP Morgan Chase sold out of Safeguard Scientifics, Inc. (SFE) in Q1 2024, closing a stake of 21 shares — an estimated $16 sold.
JP Morgan Chase first reported a position in SFE in Q2 2013 and held it in 36 quarters. The position peaked at $1.67M in Q1 2014. 4 funds tracked by Wall St. Rank hold SFE as of Q1 2024.
- JP Morgan Chase reported no remaining Safeguard Scientifics, Inc. position as of Q1 2024 after selling out during the quarter.
- JP Morgan Chase sold 21 Safeguard Scientifics, Inc. shares in Q1 2024, an estimated $16.
- JP Morgan Chase first reported a position in Safeguard Scientifics, Inc. in Q2 2013 and held it in 36 quarters.
- JP Morgan Chase's Safeguard Scientifics, Inc. position peaked at $1.67M in Q1 2014.
- 4 funds tracked by Wall St. Rank held Safeguard Scientifics, Inc. as of Q1 2024.
Based on JP Morgan Chase's 13F filing for Q1 2024, filed 10 May 2024.